An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Sulindac is classified as a nonsteroidal anti-inflammatory drug (NSAID), exhibiting anti-inflammatory and analgesic properties. Similar to other NSAIDs, sulindac is primarily utilized for the treatment of conditions characterized by acute or chronic inflammation. However, according to the manufacturer, its indications are broad. The medication is prescribed for the acute management of musculoskeletal shoulder pain, acute gouty arthritis, osteoarthritis resulting from wear and tear, and inflammatory arthritic conditions, including both rheumatoid arthritis and ankylosing spondylarthritis. Healthcare providers recommend administering the lowest effective dose tailored to each patient's needs for the initial treatment and the shortest duration possible. This activity provides an overview of the indications, contraindications, mechanism of action, adverse events, and essential components of sulindac therapy in clinical practice. This activity enables healthcare professionals to tailor treatment plans, optimize dosage regimens, and minimize adverse reactions by enhancing their competence in sulindac pharmacology.
Karachalios GN, Donas G. Sulindac in the treatment of acute gout arthritis. Int J Tissue React. 1982;4(4):297-9.
-
PubMed
Gurpinar E, Grizzle WE, Piazza GA. COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs. Front Oncol. 2013;3:181.
-
PMC
-
PubMed
Herzig D, Hardiman K, Weiser M, You N, Paquette I, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes. Dis Colon Rectum. 2017 Sep;60(9):881-894.
-
PMC
-
PubMed
Saad J, Mathew D. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jul 17, Nonsteroidal Anti-Inflammatory Drugs Toxicity.
-
PubMed
Yin T, Wang G, Ye T, Wang Y. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. Sci Rep. 2016 Jan 18;6:19534.
-
PMC
-
PubMed
